Kenvue Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Kenvue Inc.
Kenvue is the world’s largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue’s brands are the global leader in their respective segment thanks to their strong brand power.
/ 
Frequently asked questions
To buy Kenvue Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Kenvue Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Kenvue Inc. is KVUE:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Kenvue Inc. has its primary listing on New York Stock Exchange. You can trade Kenvue Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Kenvue Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Kenvue Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Kenvue Inc..